Prevention of rheumatoid arthritis by atorvastatin in seropositive arthralgia patients: a multi-center doubleblind randomized placebo-controlled trial

Trial Profile

Prevention of rheumatoid arthritis by atorvastatin in seropositive arthralgia patients: a multi-center doubleblind randomized placebo-controlled trial

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 28 Nov 2016

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms STAPRA
  • Most Recent Events

    • 25 Apr 2015 Primary drug has been changed from Rosuvastatin to Atorvastatin.
    • 25 Apr 2015 Planned number of patients changed from 200 to 220, according to European Clinical Trials Database record.
    • 18 Mar 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top